Clinical Trials Browser

Phase 3 × Melanoma × masitinib × Clear all

NCT01280565 2020-11-05

Masitinib in Non-Resectable or Metastatic Stage 3/4 Melanoma Carrying a Mutation in the Juxta Membrane Domain of c-Kit

Phase 3 Terminated

Melanoma